Colorectal cancer heterogeneity and targeted therapy : A case for molecular disease subtypes

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review

103 Scopus Citations
View graph of relations

Author(s)

  • Janneke F. Linnekamp
  • Xin Wang
  • Jan Paul Medema
  • Louis Vermeulen

Detail(s)

Original languageEnglish
Pages (from-to)245-249
Journal / PublicationCancer Research
Volume75
Issue number2
Publication statusPublished - 8 Aug 2015
Externally publishedYes

Abstract

Personalized cancer medicine is becoming increasingly important in colorectal cancer treatment. Especially for targeted therapies, large variations between individual treatment responses exist. Predicting therapy response is of utmost significance, as it prevents overtreatment and adverse effects in patients. For EGFRtargeted therapy, many mechanisms of resistance have been uncovered, for example, mutations in KRAS and BRAF, and upregulation of alternative receptors. Currently, routine testing for all known modifiers of response is unpractical, and as a result, decision-making for anti-EGFR therapy is still largely based on assessing the mutation status of an individual gene (KRAS). Recently, comprehensive classifications of colorectal cancer have been presented that integrate many of the (epi-)genetic and microenvironmental factors that contribute to colorectal cancer heterogeneity. These classification systems are not only of prognostic value but also predict therapy efficacy, including the response to anti-EGFR agents. Therefore, molecular subtype-based stratification to guide therapeutic decisions is a promising new strategy that might overcome the shortcomings of single gene testing in colorectal cancer as well as in other malignancies. Furthermore, the development of new agents in a disease subtype-specific fashion has the potential to transform drug-discovery studies and generate novel, more effective therapies.

Citation Format(s)

Colorectal cancer heterogeneity and targeted therapy : A case for molecular disease subtypes. / Linnekamp, Janneke F.; Wang, Xin; Medema, Jan Paul; Vermeulen, Louis.

In: Cancer Research, Vol. 75, No. 2, 08.08.2015, p. 245-249.

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review